Abstract

BackgroundNeutrophil gelatinase-associated lipocalin (NGAL or LCN2) is an iron-transporting factor which possesses various activities such as amelioration of kidney injury and host defense against pathogens. Its circulating concentrations are elevated in acute and chronic kidney diseases and show a positive correlation with poor renal outcome and mortality, but its clinical significance in maintenance hemodialysis (HD) patients remains elusive.MethodsSerum NGAL levels were determined by enzyme-linked immunosorbent assay in out-patient, Japanese HD subjects. Their correlation to laboratory findings and morbidity (as development of severe infection or serum albumin reduction) was investigated using linear regression analysis and χ2 test.ResultsPre-dialysis serum NGAL levels in HD patients were elevated by 13-fold compared to healthy subjects (n=8, P<0.001). In a cross-sectional study of 139 cases, serum NGAL concentrations were determined independently by % creatinine generation rate (an indicator of muscle mass, standardized coefficient β=0.40, P<0.001), peripheral blood neutrophil count (β=0.38, P<0.001) and anion gap (which likely reflects dietary protein intake, β=0.16, P<0.05). Iron administration to anemic HD patients caused marked elevation of peripheral blood hemoglobin, serum ferritin and iron-regulatory hormone hepcidin-25 levels, but NGAL levels were not affected. In a prospective study of 87 cases, increase in serum albumin levels a year later was positively associated to baseline NGAL levels by univariate analysis (r=0.36, P<0.01). Furthermore, within a year, patients with the lowest NGAL tertile showed significantly increased risk for marked decline in serum albumin levels (≥0.4 g/dl; odds ratio 5.5, 95% confidence interval 1.5–20.3, P<0.05) and tendency of increased occurrence of severe infection requiring admission (odds ratio 3.1, not significant) compared to the middle and highest tertiles.ConclusionLow serum NGAL levels appear to be associated with current malnutrition and also its progressive worsening in maintenance HD patients.

Highlights

  • Neutrophil gelatinase-associated lipocalin (NGAL, lipocalin 2 or LCN2) was initially purified from neutrophils but with unknown function [1]

  • Low serum NGAL levels appear to be associated with current malnutrition and its progressive worsening in maintenance HD patients

  • Serum NGAL levels were significantly correlated to other markers of nutrition such as serum albumin (r = 0.29, P

Read more

Summary

Introduction

Neutrophil gelatinase-associated lipocalin (NGAL, lipocalin 2 or LCN2) was initially purified from neutrophils but with unknown function [1]. NGAL prevents acute kidney injury (AKI) [6], activates kidney differentiation [7] and modulates cancer metastasis [8, 9]. With respect to regulation of NGAL expression, kidney injury [3, 6, 13], infection [10, 14], inflammation [15], and malignancy [8, 9] are major inducers of expression in epithelial and non-epithelial cells, but the role of iron status itself in regulation of NGAL, especially among end-stage renal disease patients, remains largely unknown. Neutrophil gelatinase-associated lipocalin (NGAL or LCN2) is an iron-transporting factor which possesses various activities such as amelioration of kidney injury and host defense against pathogens. Its circulating concentrations are elevated in acute and chronic kidney diseases and show a positive correlation with poor renal outcome and mortality, but its clinical significance in maintenance hemodialysis (HD) patients remains elusive

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call